Skip to Main Content

Paper Details

The association between immune checkpoint or BRAF/MEK inhibitor therapy and uveitis in patients with advanced cutaneous melanoma.
Eur J Cancer
7
2021
BRAF, MEK, Melanoma, PATIENTS, advanced cutaneous melanoma, legal blindness, metastatic malignancies, patients, uveitis
Author NameAffiliation
Nicholas MitsakakisInstitute of Health Policy, University of Toronto
Reinhard DummerUniversity Hospital of Zurich
Reinhard DummerUniversity Hospital of Zurich
  • 1 - 3

Datasets

Release 1.2